TB 101 Disease, Clinical Assessment and Lab Testing
|
|
- Jordan Johnson
- 6 years ago
- Views:
Transcription
1 TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout
2 None Disclosure
3 Objectives Be able to list and explain the test methods available and turn-around-times for MTB testing. Understand and be able to explain the mycobacteriology testing algorithm for the following MTB test methods: AFB smear, culture, NAAT and drug susceptibility testing. Be able to explain possible reasons for uncommon and unexpected MTB test results. Be able to discuss the clinical impact of uncommon or unexpected MTB test interpretations.
4 M. tuberculosis Culture, Molecular and Clinical Laboratory Testing Nucleic acid testing -RNA, DNA -Viable and non-viable -MTB growth confirmed by direct nucleic acid probe detection -MTB nucleic acid amplification (NAAT) -GeneXpert MTB/RIF (PCR) Interferon Gamma Release Assay (IGRA) -QuantiFERON -TB Gold -ELISpot (T-SPOT.TB) Culture -Viability -Transport considerations -Collection to processing -Shipping and handling -Drug susceptibility testing (DST) -Limit of detection -MTB fitness in culture
5 Mycobacterial Testing Culture, Identification and DST Methods Microscopy & AFB stains Types Ziehl-Neelsen ( Hot ) Kinyoun ( Cold ) Auramine ( Fluorescent ) LOD (10K bacteria/ml) Direct AFB smear (ZN/K sensitivity 20 80%) Not M. tuberculosis specific Hours for processing and testing Experienced technologist
6 Mycobacterial Testing Culture, Identification and DST Methods Culture (Liquid/solid media) Solid (e.g. Middlebrook, Lowenstein- Jensen ), liquid (MGIT realtime) LOD (Single viable MTB) Culture identification Phenotypic and Biochemical tests (e.g. Niacin, Nitrate) Molecular is more common Nucleic acid probes» MTB, MAC, M. kansasii, M. gordonae (Hologic, Accuprobe) Sequencing (16S, Pyrosequencing) HPLC MALDI TOF MS (NTM) 2-8 weeks for final result Highly experienced technologists
7 Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis MMWR - January 16, 2009 / 58(01);7-10 AFB smear with the added value of NAA testing Greater positive predictive value (>95%) with AFB smear-positive specimens in settings in which nontuberculous mycobacteria are common Confirm rapidly the presence of M. tuberculosis in 50%--80% of AFB smear-negative, culture-positive specimens. Compared with culture, NAA tests can detect the presence of M. tuberculosis bacteria in a specimen weeks earlier than culture for 80%--90% of patients suspected to have pulmonary TB whose TB is ultimately confirmed by culture. Can impact patient care and TB control efforts Avoiding unnecessary contact investigations or respiratory isolation for patients whose AFB smear-positive specimens do not contain M. tuberculosis.
8 Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis MMWR - January 16, 2009 / 58(01);7-10 Culture remains the gold standard for laboratory confirmation of TB and is required for isolating bacteria for drug-susceptibility testing and genotyping. NAA testing should become standard practice for patients suspected to have TB. NAA testing for TB can shorten the time needed to diagnose TB from 1--2 weeks to 1--2 days. More rapid laboratory results should lead to earlier treatment initiation, improved patient outcomes, and increased opportunities to interrupt transmission. Rapid laboratory confirmation of TB also can help reduce inappropriate use of fluoroquinolones as empiric monotherapy of pneumonias (i.e. Can lead to development of fluoroquinolone-resistant M. tuberculosis).
9 Mycobacterial Testing Culture, Identification and DST Methods Drug susceptibility testing (DST) Phenotypic methods Culture and susceptibility testing 2-4 weeks (e.g. MGIT, agar proportion) Genotypic methods RealTime PCR Molecular Beacons (Selected labs)» 2-4 hours» Rifampin (rpob gene) INH (katg, inha, aphc, ndh) Heminested realtime PCR» Cepheid Xpert MTB/RIF Mtb direct and concentrated detection with rifampin resistance detection 2 hours Line Probe (Inno-Lipa) HAIN GTMD Sequencing and Rep-PCR 4-8 hours Next generation sequencing (NGS) 1. Inoculate broth wells containing bacterial inhbitiors, growth supplements, and antibiotic dilutions with 800 µl decontaminated sputum 2. Examine wells through an inverted microscope starting on day seven (7).
10 Phenotypic Drug Susceptibility Testing (DST) M. tuberculosis Culture and detection of M. tuberculosis growth in the presence of anti-tb drugs Proportion, resistance ratio or absolute concentration methods on solid media (3 weeks) Broth-based semiautomated (4 12 days) BACTEC MGIT 960 TB system MGIT 960 system may be used directly on sputum samples, additional time and labor is needed for identification of M. tuberculosis. Other phenotypic tests Liquid media-based microscopic observation drug susceptibility (MODS) test Phage-based assays using mycobacteriophages
11 Countries reporting XDR-TB as of February 2008 (Based on information provided to WHO Stop TB Department) 1-5 Any drug-resistant TB describes TB with resistance to one of multiple drugs. Multidrug-resistant TB (MDR-TB) is defined as having resistance to the two most potent anti-tb drugs, isoniazid and rifampin. Extensively drug-resistant TB (XDR-TB) is newly defined as having multidrug resistance (resistance to isoniazid and rifampin) as well as resistance to at least two additional second-line medications, a fluoroquinolone and one or more injectable agents (amikacin, kanamycin, or capreomycin). 1. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194: Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993;329(11): Weyer K, Lancaster J, Brand J, van der Walt M, Levin J. Survey of tuberculosis drug resistance in South Africa Paper presented at: Medical Research Council; 2004; Pretoria, South Africa. 4. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, MMWR. 2006;55: Shah NS, Wright A, Bai GH, et al. Emergence of extensively drug resistant tuberculosis. Emerg Infect Dis. 2007;13(3):
12 M. TUBERCULOSIS, DRUG RESISTANCE GENES AND THE DEVELOPMENT OF RAPID METHODS FOR DRUG RESISTANCE DETECTION (I.E. MDR-TB/XDR-TB) S. Ahmad, et.al Res. Med. 103:1777
13 Rifampin Drug Resistance Rifampin (RIF), a lipophilic rifamycin derivative, binds to b- subunit of RNA polymerase (encoded by rpob) and inhibits RNA transcription ( protein synthesis) in Mtb 23 Mutations in rpob gene confer RIF resistance (drug binding) Monoresistance to RIF is rare except in HIV-co-infected patients RIF resistance is often a surrogate marker for MDR-TB 85-90% RIF resistant strains are also resistant to INH 90-95% of RIF-resistant strains carry missense mutations or small in-frame insertions/deletions within an 81-bp hotspot region (HSR) mainly involving rpob codons 531, 526 and 516 Resistance in 5-10% RIF-resistant isolates is due to mutations in N-terminal or other regions of the rpob gene or due to some unknown mechanism. Adapted from: S. Ahmad, et.al Res. Med. 103:1777
14 Boehme, et.al. NEJM 363:1005. Sept. 9,
15 Mycobacteriology Testing Scheme
16 Mycobacteriology Testing Scheme
17
18 Mycobacteriology Testing Scheme
19 Mycobacteriology Testing Scheme
20 Clinical Case #1
21 Laboratory Findings Non-tuberculosis mycobacteria (NTM) overgrowth What is the significance of NTM growth? Will M. tuberculosis recovery be possible with the co-isolation of NTM in culture? What are the alternatives for the approach to laboratory testing in the case of NTM overgrowth?
22 Clinical Case #2
23 Laboratory Findings Non-AFB overgrowth with specimen redigest What is the cause of non-afb overgrowth? Can this situation be prevented in any subsequent specimen recollections? This specimen has been treated 2X with NaOH, can we redigest a 3 rd time? If a third NaOH digest is performed, what is the effect on M. tuberculosis culture recovery?
24 Clinical Case #3
25 Laboratory Findings Gastric specimen with delayed specimen neutralization and no growth on culture Why is it important to list the specific source of the specimen for MTB AFB smear and culture? How is a gastric specimen different from a respiratory or other type of specimen? Are gastric specimens handled and transported differently from respiratory specimens?
26 Gastric Aspirate Collection and Processing Usually performed in young children Early morning collection (NPO required) Sodium carbonate neutralization to ph 7.0 Add 100 mg sodium carbonate/5-10 ml of gastric aspirate specimen following collection
27 Clinical Case #4
28 Laboratory Findings Direct USAPI AFB smear negative with DLS concentrated >+/- 1 grade and MTB growth Why is there a concern when the direct AFB smear is >+/- 1 grade from the concentrated smear? What is the possible consequence of this type of AFB smear discordance? What is the root cause of this type of discordance? Specimen? Technologist? Other causes?
29 Clinical Case #5
30 Laboratory Findings AFB smear positive and Xpert MTB/RIF Detected/Not Detected and NO MTB cultured How would this type of finding be interpreted to the ordering HCP? What if this finding was the result of a first time specimen collection on a new MTB, untreated patient? Specimen collection issue? Specimen handling and transport issue? Specimen processing issue? Specimen analytical or post-analytical phase issue?
31 MAJURO EBEYE
TB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationStacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona
Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationFrances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS
The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationWELCOME. Lab Talk: What a Nurse Hears. April 18, NTNC Annual Meeting Lab Talk: What a Nurse Hears
Lab Talk: What a Lab Talk: What a Max Salfinger, MD, FIDSA, FAAM Executive Director, Advanced Diagnostic Laboratories Laboratory Director, Mycobacteriology & Pharmacokinetics National Jewish Health Lisa
More informationCDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014
TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationTB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai
TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%
More informationThe ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory
The ABC s of AFB s Laboratory Testing for Tuberculosis Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory Laboratory TAT Goals Case Study Specimen Collection Testing Contact
More informationTB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012
TB Nurse Case Management San Antonio, Texas March 7-9, 2012 Diagnosis of TB: Laboratory Ken Jost Wednesday March 7, 2012 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationDrug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER
Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility
More informationObjectives. TB Laboratory Methods
TB Laboratory Methods Beverly Metchock, Dr.P.H., D(ABMM) Team Leader, Reference Laboratory, Mycobacteriology Laboratory Branch February 2011 Objectives General overview of mycobacteriology (TB) lab practices
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationReceipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen
Recommendation Promote rapid delivery of specimens to the laboratory Use fluorescent acid-fast staining and promptly transmit results by phone, FAX, or electronically Identify growth as acid-fast and use
More informationDiagnosis and Management of Active Tuberculosis
Diagnosis and Management of Active Tuberculosis Zelalem Temesgen, MD FIDSA AAHIVS 2013 MFMER slide-1 Disclosures None 2013 MFMER slide-2 Objectives By the end of this session, participants should be able
More informationTB is Local. Barry Chin, Boston Globe, 10/15/2008. * BUT only in appropriate setting
Diagnosis of Tuberculosis 2012 New Tools, Tricks, Thinking? John Bernardo, M.D. Pulmonary Section, Boston University School of Medicine Massachusetts Department of Public Health Objectives To review the
More informationWSLH Testing and Surveillance Updates
WSLH Testing and Surveillance Updates Wisconsin Mycobacteriology Laboratory Network annual conference November 4, 2015, Madison, WI Updates Outline Collection and Transport Smear and Culture Nucleic Acid
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationLaboratory Diagnosis and Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis Complex. Objectives
Laboratory Diagnosis and Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis Complex Marie-Claire Rowlinson, PhD D(ABMM) Calin Chiribau, PhD, MT(ASCP) Florida Bureau of Public Health Laboratories
More informationPrinciples of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017
Principles of laboratory diagnosis of M. tuberculosis Anne-Marie Demers, MD, FRCPC 11 September 2017 QUESTION Which statement is false? 1) A smear can only be on a concentrated specimen 2) It is normal
More informationMycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods
Laboratory Methods Cell Cycle Lengths Generation time (hrs) Days needed for 26 generations (colony) E. coli 0.33 0.36 Nancy Connell, PhD Professor, nfectious Disease Department of Medicine Center for Emerging
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationMycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline
Mycobacteria Diagnostic Testing in Manitoba Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Acknowlegements: Assunta Rendina: Charge Tech HSC Lab Joyce Wolf & Dr. Meenu Sharma: NML Dr. Kanchana
More informationRapid Diagnosis and Detection of Drug Resistance in Tuberculosis
Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis YAM Wing-Cheong 任永昌 Department of Microbiology The University of Hong Kong Tuberculosis Re-emerging problem in industrialized countries
More informationDST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?
DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and
More informationNAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL
NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL Susan Novak-Weekley, S(M), ASCP, Ph.D., D(ABMM) Director of Microbiology,
More informationChapter 4 Diagnosis of Tuberculosis Disease
Chapter 4 Diagnosis of Tuberculosis Disease Table of Contents Chapter Objectives.... 75 Introduction.... 77 Medical Evaluation.......................................................... 78 Chapter Summary...
More informationResearch Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012
Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How
More informationRole of the Laboratory in TB Diagnosis and Management
Role of the Laboratory in TB Diagnosis and Management Michael Pentella, Ph.D., D(ABMM), CIC Associate Director University Hygienic Lab Clinical Associate Professor, College of Public Health, University
More informationCommunication between clinician and laboratory Molecular detection of M. tuberculosis complex
3 Laboratory 3rd edition contributors: PENNAN M. BARRY, MD, MPH & SHOU-YEAN GRACE LIN, MS General information on TB laboratory work..................... 32 Molecular methods for detection of M. tuberculosis
More informationLaboratory Diagnosis for MDR TB
Laboratory Diagnosis for MDR TB Neha Shah MD MPH Centers for Disease Control and Prevention Division of Tuberculosis Elimination California Department of Public Health Guam March 07 Objectives Describe
More informationMolecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria
Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis Dr Sahajal Dhooria What is drug resistant TB? Definitions MDR TB defined as resistance to isoniazid and rifampicin, with or without resistance
More informationNucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services
Nucleic Acid Amplification Test for Tuberculosis Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services What is this test? Nucleic Acid Amplification Test (NAAT)
More informationNucleic Acid Amplification Testing for the Diagnosis of TB
Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm
More informationDiagnosis of tuberculosis
Diagnosis of tuberculosis Madhukar Pai, MD, PhD Assistant Professor, Epidemiology McGill University, Montreal, Canada madhukar.pai@mcgill.ca Global TB Case Detection A major concern 2.6 million new smear
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationXpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it
Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Angela Starks, PhD Chief, Laboratory Branch Division of TB Elimination Matt Bankowski, PhD, MS, D(ABMM), HCLD/CC(ABB)
More informationRapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008
Tuberculosis Updates for Clinicians San Antonio, Texas November 13, 2008 Rapid Diagnostic Techniques for Identifying Tuberculosis Ken Jost November 13, 2008 Rapid Diagnostic Techniques for Identifying
More informationPublic Health Mycobacteriology (TB) Laboratory Testing Services
Public Health Mycobacteriology (TB) Laboratory Testing Services Gary Budnick Supervising Microbiologist Connecticut Department of Public Health Laboratory Branch Hartford, Connecticut Specimen Collection
More informationCDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service
CDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service Beverly Metchock, DrPH, D(ABMM) Team Lead, Reference Laboratory
More informationTB Nurse Case Management Davenport, Iowa September 27 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Role of the Laboratory in the TB Diagnosis and Management Michael Pentella, PhD, MS, SM(ASCP), CIC, D(ABMM) September 27, 2011 Michael Pentella,
More informationWhen good genes go bad
When good genes go bad Dr Kessendri Reddy NHLS Tygerberg Hospital Division of Clinical Microbiology Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine and Health Sciences Overview Cases
More informationEpidemiology and diagnosis of MDR-TB in children H Simon Schaaf
Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions
More informationUse of the Cepheid GeneXpert to Release Patients from Airborne Isolation
Use of the Cepheid GeneXpert to Release Patients from Airborne Isolation Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene WISCONSIN STATE LABORATORY
More informationLABORATORY METHODS: TUBERCULOSIS DIAGNOSIS
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE LABORATORY METHODS: TUBERCULOSIS DIAGNOSIS LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe three laboratory
More informationTB Updates for the Physician Rochester, Minnesota June 19, 2009
TB Updates for the Physician Rochester, Minnesota June 19, 2009 Mycobacterial Laboratory Science Update Nancy L. Wengenack, Ph.D. Associate Professor of Laboratory Medicine and Pathology Division of Clinical
More informationGuidelines for Tuberculosis Control in New Zealand 2010 Chapter 11: Mycobacteriology: Laboratory Methods and Standards
Guidelines for Tuberculosis Control in New Zealand 2010 Chapter 11: Mycobacteriology: Laboratory Methods and Standards Ministry of Health. 2010. Guidelines for Tuberculosis Control in New Zealand 2010.
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationDiagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology: A Short Review
International Journal of Advanced Microbiology and Health Research www.ijamhr.com Volume 1; Issue 1; September 2017; Page No. 20-24 Review Article Diagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology:
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationTHE ROLE OF THE LABORATORY
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE NOVEMBER 1-4, 2016 THE ROLE OF THE LABORATORY LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe three
More informationTHE ROLE OF THE LABORATORY
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE THE ROLE OF THE LABORATORY LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe three laboratory methods
More informationLaboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust
Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral
More informationXpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults(review)
Cochrane Database of Systematic Reviews Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults(review) SteingartKR,SohnH,SchillerI,KlodaLA,BoehmeCC,PaiM,DendukuriN SteingartKR,SohnH,SchillerI,KlodaLA,BoehmeCC,PaiM,DendukuriN.
More informationHow best to structure a laboratory network with new technologies
How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics
More informationEvaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis
Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt
More informationShah: Discordant Growth- Molecular Rifampin Resistance 2/27/16 RELAPSED FAILED
/7/6 Discordant Growth- Molecular Diagnos7c Challenges and Treatment Outcomes Neha Shah, MD MPH Centers for Disease Control and Preven7on California Department of Health Tuberculosis Control NAR February
More informationXpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)
Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review) Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N This is a reprint of a Cochrane review,
More informationResearch in Tuberculosis: Translation into Practice
Case History Research in Tuberculosis: Translation into Practice This is a 6-year6 year-old Bosnian male, who presented to ER with one-week history of fever and occasional vomiting. No cough, difficulty
More informationTB Update: March 2012
TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their
More informationA retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece
Örebro University School of Health and Medical Science Biomedical Laboratory Science Programme 180 credits Degree project in biomedical laboratory science, advanced course, 15 credits May 21, 2015 A retrospective
More informationPCR and direct amplification for tuberculosis diagnosis. Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital,
PCR and direct amplification for tuberculosis diagnosis Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital, Paris, France Educational Workshop 05- ECCMID 2015 Copenhagen
More informationCULTURE OR PCR WHAT IS
CULTURE OR PCR WHAT IS BEST FOR AFRICA? Peter R Mason BRTI TB IN AFRICA GLOBAL 9 MILLION NEW CASES/YR 1.5 MILLION TB DEATHS AFRICA 95% TB DEATHS IN LMIC 9/22 HIGH BURDEN COUNTRIES IN AFRICA STRONG LINK
More informationMicroscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis
Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 179 Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis complex,
More informationDiagnosis of tuberculosis in children
Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence
More informationNOLA TB TIMES. TB Diagnostics A Special Issue. on TB Diagnosis 101. Diagnostic Discrepancy Data. Comprehensive Approach
NOLA TB TIMES Volume 1, No 3 February 2016 TB Diagnostics A Special Issue on TB Diagnosis 101 Happy New Year and Happy Mardi Gras to everyone! We already have seven presumptive cases of tuberculosis (TB)
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationRapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients.
Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients. Item Type Thesis Authors Patel, Ravikumar Publisher The University of Arizona. Rights Copyright
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationMolecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria
Niger. J. Physiol. Sci. 28(December 2013) 187 191 www.njps.com.ng Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria * 1 Kehinde A.O. and 2 Adebiyi, E.O. Department of Medical
More informationTB BASICS: PRIORITIES AND CLASSIFICATIONS
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE NOVEMBER 1-4, 2016 TB BASICS: PRIORITIES AND CLASSIFICATIONS LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1.
More informationFrances Jamieson, MD and Kevin May, BSc November 15 th,
Frances Jamieson, MD and Kevin May, BSc November 15 th, 2016 1 TB Elimination: Back To Basics Financial Interest Disclosure (over the past 24 months) Dr. Frances amieson Company Speaker Advisory Research
More informationThe MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study
The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal
More informationHarmonizing the Use of Molecular & Culture-based DST of Mycobacterium tuberculosis
Harmonizing the Use of Molecular & Culture-based DST of Mycobacterium tuberculosis Grace Lin, MS. Research Scientist grace.lin@cdph.ca.gov APHL 8 th TB Lab Conference San Diego 8-19-13 Harmonizing? There
More informationElizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.
The image part with relationship ID rid2 was not found in the file. MDR TB Management Review of the Evolution (or Revolution?) Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist,
More informationDiagnosis of Extra Pulmonary Tuberculosis By Using Xpert MTB/RIF Assay (CBNAAT) And MGIT Liquid Culture.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 9 Ver. 10 (September. 2018), PP 65-70 www.iosrjournals.org Diagnosis of Extra Pulmonary Tuberculosis
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationOriginal Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
Int J Clin Exp Pathol 2017;10(4):4847-4851 www.ijcep.com /ISSN:1936-2625/IJCEP0045802 Original Article Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
More informationAssessing the programmatic management of drug-resistant TB
Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many
More informationNew frontiers: Innovation and Access
8th Regional TB Symposium Tashkent, Uzbekistan Prof. L.N. Chernousova Central Tuberculosis Research Institute (CTRI) Ministry of Health of the Republic of Uzbekistan 28 February 1 March, 2019 1970 1975
More informationComparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium tuberculosis
Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 45, no. 3, 2015 327 Comparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium tuberculosis
More informationDetection of Multidrug Resistance and Characterization of Mutations in Mycobacterium tuberculosis Isolates in Raichur District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 1543-1549 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.185
More informationEvaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria
RESEARCH ARTICLE Open Access Journal of Infectious Diseases and Pathogenesis ISSN 577-7939 Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC
More informationGeneral Session IV - Dale Schwab April 20, 2017
The Culture of Clinical Commercial Labs Presented by: Dale Schwab PhD, Senior Scientific Director, Infectious Disease April 20, 2017 Objectives Challenges for the reference laboratory in MTB diagnosis/opportunities
More informationResearch Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System
BioMed Research International Volume 2016, Article ID 5972021, 4 pages http://dx.doi.org/10.1155/2016/5972021 Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by
More informationMycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE
Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting
More informationTargeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease
Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will
More informationNew Standards for an Old Disease:
New Standards for an Old Disease: Practical Implications of the TB Standards TB Prevention and Control Saskatchewan September 16, 2015 Practical Implications of the TB Standards Learning Objectives At
More informationXpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)
Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review) Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N This is a reprint of a Cochrane review, prepared
More informationTUBERCULOSIS. Pathogenesis and Transmission
TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationCase Study 2016 Wisconsin Mycobacteriology Laboratory Network Annual Conference November 17, 2016
Case Study 2016 Wisconsin Mycobacteriology Laboratory Network Annual Conference November 17, 2016 Raymond P. Podzorski, Ph.D, D(ABMM) St. Mary s Hospital Laboratory and Wisconsin Region SSMHealth 608-258-6393
More informationAFB Identification Texas Approach
AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175
More informationMolecular assays in Tuberculosis. Jatin Yegurla Junior resident
Molecular assays in Tuberculosis Jatin Yegurla Junior resident 17-3-2018 Contents Introduction TB-PCR Line Probe assay (LPA) GenoType MTBDRsl test (Second line LPA) Xpert MTB/RIF (GeneXpert) (CB-NAAT)
More informationA Clinician s Guide to the TB Laboratory
A Clinician s Guide to the TB Laboratory EXCELLENCE EXPERTISE INNOVATION Dear Healthcare Professional, This book provides basic information on the use of the public health and clinical laboratories in
More information